Investors in Health

VAS Ventures, led by serial entrepreneur Martin Varsavsky, focuses on early stage investments in companies with ambitious founders driving innovation. Known for his successful ventures and investments in transformative startups, Martin Varsavsky personally mentors portfolio companies, leveraging his entrepreneurial expertise and network to foster their growth and success. VAS Ventures is an early stage investment fund looking for companies in the mobility, mobile and SaaS space.

Plug and Play is renowned as the ultimate innovation platform, dedicated to constructing the world's foremost innovation ecosystem and democratizing access to innovation worldwide. Their mission revolves around connecting entrepreneurs, corporations, and investors on a global scale. Over the last 15 years, Plug and Play has successfully integrated over 35,000 startups, 500 leading corporations, and numerous venture capital firms, universities, and government agencies across more than 20 diverse industries. With a presence in over 50 locations worldwide, including the U.S., China, France, Germany, South Africa, Singapore, Indonesia, and Brazil, Plug and Play collaborates with its partners to foster a unique ecosystem. This ecosystem facilitates impactful networking opportunities, invests in promising startups, and aligns key stakeholders to drive innovation forward.

Invivo Partners is a venture capital firm specializing in early-stage healthcare companies, led by Luis Pareras, Albert Ferrer, and Laura Rodríguez. With investments in 15 portfolio companies and 3 successful exits, their portfolio companies have collectively raised over 350M€ from global VCs. The team at Invivo Partners combines scientific, technical, and financial expertise to make impactful investments and drive growth in the health sector. With a strong focus on Technology Transfer and market trends, the firm aims to establish itself as a key player in Europe's biotech industry. Invivo Partners' investor base includes major institutional investors such as the European Investment Fund, Instituto de Crédito Oficial (ICO), Institut Català de Finances (ICF), Institut Valencià de Finances (IVF), Barcelona City Council, alongside a majority of private investors. Initial investments typically range from 2-4M€, with follow-on investments up to 10M€ per company after achieving specified milestones. The firm specializes in pre-seed and seed investments, particularly in companies at the preclinical stage, and also participates in Series A investments for companies approximately 1-2 years away from First-in-Human trials. Invivo Partners focuses primarily on European-based opportunities, with a special emphasis on Spanish biotechnology companies developing innovative drugs, particularly in Advanced Therapies and Synthetic Biology.

Clave is an investment management company. Their cornerstone is commitment. They advance innovative projects and industrial SMEs through strategic investments and active engagement in the company's value creation journey. Their hallmark is professionalism, boasting over 16 years of experience marked by more than 65 investments. They specialize in shaping strategy and management across diverse sectors including technology, renewable energy, agri-food, among others. They emphasize team integration, fostering collaborative partnerships with founders and management teams. This approach aims to bolster company growth and tackle emerging market demands effectively.

Clave is an investment management company. Their cornerstone is commitment. They advance innovative projects and industrial SMEs through strategic investments and active engagement in the company's value creation journey. Their hallmark is professionalism, boasting over 16 years of experience marked by more than 65 investments. They specialize in shaping strategy and management across diverse sectors including technology, renewable energy, agri-food, among others. They emphasize team integration, fostering collaborative partnerships with founders and management teams. This approach aims to bolster company growth and tackle emerging market demands effectively.

Aldea Ventures is a Barcelona-based pan-European venture capital platform specializing in investing in the next generation of technology leaders. Founded in 2020, they employ a pioneering hybrid strategy: supporting specialized emerging fund managers in early-stage investments while co-investing in growth-stage companies. Their diverse portfolio includes over 50 fund managers and companies like Automata, Kenbi, Podimo, Sorare, as well as funds such as Moonfire and Cocoa. Aldea Ventures aims to advance cutting-edge technologies across Europe, connecting VC talent with startup ecosystems and enhancing their understanding of the European tech landscape.